Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

Saved in:
Bibliographic Details
Title: Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.
Authors: Chen LY; University of Oxford, Oxford, United Kingdom., Aleman A; Icahn School of Medicine at Mount Sinai, New York, New York, United States., Larrayoz M; CIMA, Pamplona, Spain., Chiu H; Bristol-Myers Squibb, Summit, New Jersey, United States., Zhao J; Bristol-Myers Squibb, Summit, New Jersey, United States., Van Oekelen O; Icahn School of Medicine at Mount Sinai, New York, New York, United States., Kelly G; Icahn School of Medicine at Mount Sinai, New York, New York, United States., Kim-Schulze S; Mount Sinai School of Medicine, New york, New York, United States., Lagana A; Icahn School of Medicine at Mount Sinai, New York, New York, United States., Jagannath S; Mt. Sinai Medical Center, New York, New York, United States., Chow TT; Bristol-Myers Squibb, Summit, New Jersey, United States., Lozano T; Centro de Investigación Médica Aplicada, CIMA, Pamplona, Spain., Lasarte JJ; Centro de Investigación Médica Aplicada, CIMA, Pamplona, Spain., Hamley JC; University of Oxford, Oxford, United Kingdom., Baker W; University of Oxford, Oxford, United Kingdom., Ebert BL; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Oppermann U; University of Oxford, Oxford, United Kingdom., Amatangelo MD; Bristol-Myers Squibb, Madison, New Jersey, United States., Gandhi AK; Bristol-Myers Squibb, Summit, New Jersey, United States., Hagner PR; Bristol-Myers Squibb, Summit, New Jersey, United States., Martínez-Climent JA; Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain., Gooding S; University of Oxford, Oxford, United Kingdom., Milne TA; University of Oxford, Oxford, United Kingdom., Parekh S; Icahn School of Medicine at Mount Sinai, NEW YORK, New York, United States.
Source: Blood [Blood] 2026 May 08. Date of Electronic Publication: 2026 May 08.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood.2025030891